Resilient Biopharma Leadership With Ambrx's Dan O'Connor

Business Of Biotech - Ein Podcast von Matt Pillar - Montags

Kategorien:

We love to hear from our listeners. Send us a message. Since Dan O'Connor stepped in as CEO at Ambrx late last year, the company's stock has rallied on the revival of a previously-shelved anti-HER2 ADC. It also raised $78 million and completed its ATM (at-the-market) offering. O'Connor is no stranger to overcoming adversity. A former marine captain, he was among the first deployed to the Persian Gulf to fight in Operation Desert Shield. While his leadership at Ambrx is anything but militaris...

Visit the podcast's native language site